FibroBiologics
Company Description: Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.
Goal for Presentation: Build awareness
Additional Comments:
Who referred you to this application?:
Goal for Presentation: Build awareness
Additional Comments:
Who referred you to this application?:
What is your next catalyst (value inflection) update?
Endpoint data in 2026
Year Founded
2021
Lead Product in Development
Diabetic Foot Ulcer, Multiple Sclerosis, Psoriasis, Human Longevity
Development Phase of Lead Product
Phase II
Exchange
NASDAQ
Ticker
FBLG
CEO/Top Company Official
Pete OHeeron

